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Infections of Fusarium spp. and Exophiala spp. are often chronic, recalcitrant, resulting
in significant morbidity, causing discomfort, disfigurement, social isolation. Systemic
disseminations happen in compromised patients, which are often refractory to available
antifungal therapies and thereby lead to death. The antimicrobial photodynamic therapy
(aPDT) has been demonstrated to effectively inactivate multiple pathogenic fungi and
is considered as a promising alternative treatment for mycoses. In the present study,
we applied methylene blue (8, 16, and 32 µg/ml) as a photosensitizing agent and
light emitting diode (635 ± 10 nm, 12 and 24 J/cm2), and evaluated the effects
of photodynamic inactivation on five strains of Fusarium spp. and five strains of
Exophiala spp., as well as photodynamic effects on in vitro susceptibility to itraconazole,
voriconazole, posaconazole and amphotericin B, both planktonic and biofilm forms.
Photodynamic therapy was efficient in reducing the growth of all strains tested, exhibiting
colony forming unit-reductions of up to 6.4 log10 and 5.6 log10 against planktonic cultures
and biofilms, respectively. However, biofilms were less sensitive since the irradiation
time was twice longer than that of planktonic cultures. Notably, the photodynamic
effects against Fusarium strains with high minimal inhibitory concentration (MIC) values
of ≥16, 4-8, 4-8, and 2-4 µg/ml for itraconazole, voriconazole, posaconazole and
amphotericin B, respectively, were comparable or even superior to Exophiala spp.,
despite Exophiala spp. showed relatively better antifungal susceptibility profile. MIC
ranges against planktonic cells of both species were up to 64 times lower after aPDT
treatment. Biofilms of both species showed high sessile MIC50 (SMIC50) and SMIC80
of ≥16 µg/ml for all azoles tested and variable susceptibilities to amphotericin B,
with SMIC ranging between 1 and 16 µg/ml. Biofilms subjected to aPDT exhibited
a distinct reduction in SMIC50 and SMIC80 compared to untreated groups for both
species, except SMIC80 of itraconazole against Fusarium biofilms. In conclusion, in vitro
photodynamic therapy was efficient in inactivation of Fusarium spp. and Exophiala
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spp., both planktonic cultures and biofilms. In addition, the combination of aPDT and
antifungal drugs represents an attractive alternative to the current antifungal strategies.
However, further investigations are warranted for the reliable and safe application in
clinical practice.
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INTRODUCTION
Opportunistic fungi may causes cutaneous, subcutaneous and
serious invasive infections, especially in immunocompromised
and debilitated individuals. Invasive fungal infection represents
a growing threat for human health due to difficulty in
diagnosis and relatively few classes of available antifungal
agents. Fusarium spp. and Exophiala spp. are both ubiquitous
fungi commonly found in soil and on plants, and are
increasingly recognized pathogen (Li et al., 2011; Guarro, 2013).
E. dermatitidis is the leading cause of severe neurotropic
phaeohyphomycosis (Li et al., 2011) and common cause of
chromoblastomycosis; while fusariosis is, after aspergillosis,
the second most common mold infection in humans, among
which F. solani species complex and F. oxysporum species
complex are responsible for approximately 60 and 20% of the
cases, respectively (Guarro, 2013). Human infection usually
occurs as a result of inoculation of the organism through the
body surface causing local infection. Systemic dissemination,
whose prevalence is effectively growing, occurs in subjects with
underlying immunodeficiency (Li et al., 2011; Guarro, 2013),
which is often refractory to available antifungal therapies and
thereby leads to death (Filizzola et al., 2003; Guarro, 2013).
Early management of local infection is crucial to prevent life-
threatening disease. However, available antifungal drugs have
shown poor in vitro activity against Fusarium spp. (Guarro,
2013). Fusariosis is mostly refractory to treatment, with a high
mortality rate for systemic disseminations (Guarro, 2013). As
for Exophiala spp. infection, success rate was only 40–70%
although favorable in vitro activity of most antifungal drugs
has been shown (Revankar and Sutton, 2010; Kondori et al.,
2011; Patel et al., 2013). In addition to life-threatening infection,
more frequently they result in significant morbidity, causing
discomfort, disfigurement, social isolation, and they are usually
recurrent and chronic.
Biofilm formation, which is a prerequisite event toward the
development of invasive disease, has been reported to involve
in about 80% of non-acute infections in human (Davies, 2003).
Fungal biofilms, unlike planktonic forms, are relatively resistant
to conventional antifungals, which may play an important role
in the dissemination and therapeutic failure of Fusaruim and
Exophiala infections (Desai et al., 2014). However, the eradication
of biofilms is still a key challenge in the antifungal discovery
agenda. Given that fungal infections always require lengthy
antifungal therapy, alternative treatment methods are urgently
needed.
In recent years, due to its efficiency and low invasive
character, antimicrobial photodynamic therapy (aPDT) arises
as a promising alternative approach to conventional antifungal
medications, which has been demonstrated effective against
multiple pathogenic fungi in vitro (Lyon et al., 2013; Pires et al.,
2013; Arboleda et al., 2014; Morton et al., 2014; Nunes Mario
et al., 2014; Baltazar et al., 2015) and applied successfully in vivo
against cutaneous and subcutaneous mycoses (Gilaberte et al.,
2011; Lyon et al., 2011b; Souza et al., 2014). In addition, aPDT
could be a useful approach for the control of biofilms, and has
been proposed for the growth control of oral candida (Pereira
et al., 2011; Pereira Gonzales and Maisch, 2012). In vitro studies
have shown that aPDT with methylene blue and light emitting
diode (LED) was highly effective in killing Foncecaea pedrosoi,
Cladophialophora pedrosoi, Sporothrix schenckii complex species
et al. (Lyon et al., 2013; Nunes Mario et al., 2014). Lyon JP
et al. employed methylene blue as photosensitizer and a LED
device as light source, denoting the efficacy of aPDT in vivo
against chromoblastomycosis (Lyon et al., 2011b). In this trial,
an improvement of 90% of the clinical and histological aspect of
the lesions was observed in all the 10 patients (Lyon et al., 2011b).
Gilaberte et al. reported aPDT with 16% methylaminolevulinate
cream and 635 nm LED successfully treated onychomycosis
caused by the F. oxysporum, which was unresponsive to standard
antifungals (Gilaberte et al., 2011). Despite these encouraging
findings, aPDT revealed different effects against Fusarium
spp. Rose bengal-mediated aPDT has been demonstrated to
successfully inhibit the growth of F. solani (Arboleda et al., 2014).
Pre-exposure to amphotericin B allowed riboflavin combined
with long-wave ultraviolet effectiveness against Fusarium spp.
(Sauer et al., 2010), while the combination of riboflavin and long-
wave ultraviolet alone showed no antifungal effect on F. solani
(Kashiwabuchi et al., 2013). In addition, little is known regarding
the in vitro effects of aPDT on the growth and antifungal
susceptibility of Fusarium spp. and the melanized pathogen
Exophiala spp.
The aim of this study was to evaluate the effects of aPDT
mediated by methylene blue with combination of LED on the
viability of in vitro planktonic and biofilm forms of Fusaruim spp.
and Exophiala spp., and to investigate the effects of aPDT on the
antifungal susceptibilities.
MATERIALS AND METHODS
Fungal Strains
Five strains of E. dermatitidis and 5 strains of Fusarium spp. (3
strains of F. solani, and 2 strains of F. oxysporum) were studied.
All strains were clinical isolates and identified by molecular
and morphologic methods. For the dermtermiantion of in vitro
susceptibilities against antifungal agents, Candida parapsilosis
ATCC 22019 was included to ensure quality control.
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Antifungal Agents
All antifungal drugs including itraconazole (ITC; purity ≥ 99%),
voriconazole (VRC; purity≥ 99%), posaconazole (POS; purity≥
99%), and amphotericin (AMB; purity ≥ 80%) were purchased
in powder form from Sigma Chemical Co., St. Louis, MO and
prepared as outlined in the Clinical and Laboratory Standards
Institute (CLSI) broth microdilution method M38-A2 (Institute,
2008). The working concentration ranges of tested drugs were all
0.06–16 µg/ml.
Inoculum Preparation
Conidia harvested from cultures grown for 7 days on Sabouraud
dextrose agar (SDA) were suspended in sterile distilled water
containing 0.03% Triton and diluted to a concentration of 1-
5 × 106 spores/ml. One milliliter of the suspension was added
into 100 ml Sabouraud Dextrose broth. After incubation at 27◦C
in a shaker at 180 rpm for 48 h, conidia were collected and
resuspended in saline solution to obtain a suspension of 1–5 ×
106 spores/ml.
Biofilm Preparation
Conidia were collected from SDA and resuspended in 20 ml
Roswell ParkMemorial Institute-1640 (RPMI-1640). RPMI-1640
without sodium bicarbonate supplemented with L-glutamine
(Cellgro, cat. no. 50–020-PB) and buffered with 165 mM
morpholinepropanesulfonic acid (Fisher, cat. no. BP308) to pH
7 is used for biofilm preparation according to the protocol
(Pierce et al., 2008). The suspension was then adjusted to the
final concentration of 1 × 107 spores/ml. Subsequently, the
suspension was added into the 96-well plate with 200 µl in each
cell and incubated at 37◦C for 48 and 72 h for Fusarium spp.
and Exophiala spp., respectively. The media were then carefully
extracted without disturbing the biofilm. The 96-well plate was
washed with sterile PBS for three times to remove detached
spores (Pierce et al., 2008).
Photodynamic Therapy of Planktonic
Cultures
The photodynamic inactivation technique was described by
Lyon et al. (2013), with modifications in the volume used,
the incubation time, and the concentrations of methylene blue.
The methylene blue was tested at concentrations of 8 µg/ml
(T1), 16 µg/ml (T2), and 32 µg/ml (T3), with 100 µl of
each concentration mixed with 100 µl of the standardized
inocula prealiquoted into sterile 96-well microtiter plates. The
suspensions were incubated for 2 h in the dark at 37◦C. After
this period, the inocula were irradiated using a LED with an
irradiance of 100 mW/cm2 at a wavelength of 635 ± 10 nm and
at a distance of 1 cm for 120 s (12 J/cm2). The following controls
were included: fungal suspension in saline without irradiation
(C1), fungal suspension with methylene blue (16 µg/ml) and
without irradiation (C2), and fungal suspension in saline and
irradiated (C3). After the irradiation period, 10 µl aliquots from
each group were suspended with 90 µl saline, subsequently
inoculated on SDA and incubated at 37◦C for 48 and 120 h for
Fusarium spp. and Exophiala spp., respectively. The viability of
the conidia was then determined by counting colony-forming
unit (CFU). All tests were performed in triplicate.
Photodynamic Therapy of Biofilms
The methylene blue was also tested at concentrations as above,
with 100 µl of each concentration added into 96-well plates
containing biofilms. After incubation in dark for 2 h at 37◦C, the
biofilms were irradiated using a LED with an irradiance of 100
mW/cm2 at a wavelength of 635 ± 10 nm and at a distance of 1
cm for 240 s (24 J/cm2). The controls were included: biofilms in
saline without irradiation (C1), biofilms with methylene blue (16
µg/ml) and without irradiation (C2), and biofilms in saline and
irradiated (C3). After PDT treatment, 100 µl of sterile water was
added into the well and washed vigorously in order to resuspend
the biofilm cells thoroughly. The suspensions were then diluted
1000 times in sterile water and 100 µl aliquots were inoculated
evenly on SDA. The number of CFU was determined after 24 and
48 h incubation at 37◦C for Fusarium spp. and Exophiala spp.,
respectively. All tests were performed in triplicate.
In vitro Antifungal Susceptibility of
Planktonic Cultures
The individual minimal inhibitory concentrations (MICs) of
ITC, VRC, POS, and AMB on photodynamic treated (T1) and
untreated planktonic cells were determined according to M38-
A2 method (Institute, 2008). The 96-well plate was inoculated
with 100 µl of the inoculum suspension prepared and 100 µl
of the serial diluent of tested drugs. Interpretation of results
was performed after incubation at 35◦C for 48 h for Fusarium
spp. and 72 h for Exophiala spp., respectively. The MICs were
determined as the lowest concentration resulting in complete
inhibition of growth (Institute, 2008). All tests were performed
in triplicate.
In vitro Antifungal Susceptibility of Biofilms
The 96-well plate was washed with sterile PBS for three
times to remove detached spores. The individual sessile
minimum inhibitory concentrations (SMICs) of ITC, VRC,
POS and AMB on photodynamic treated (T1) and untreated
Exophiala and Fusarium biofilms were assessed by the XTT
{2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide} based colorimetric assay (Ramage et al., 2001).
After incubation at 37◦C for 48 h, 100 µl XTT/menadione
solution was added in each well and then incubated for another 4
h. Subsequently, 80 µl of the colored supernatant from each well
was removed and transferred into a new plate, and read at 490
nm. The SMIC50 and SMIC80 was defined as the concentration
at which a 50% or 80% decrease in optical density would be
detected in comparison to the controls (Pierce et al., 2008). All
tests were performed in triplicate.
Analysis of Results
For the purpose of analysis, CFU mL−1 values were transformed
into logarithm (log10). The control group C1 was considered
as 100% of growth for each set of tests. The photodynamic
inactivation efficiency was evaluated by comparing the colony
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counts after treatments T1, T2, and T3 with those obtained with
non-irradiated and methylene blue-free control colonies (C1).
The effect of photodynamic inactivation on the antifungal
susceptibility was evaluated by comparing the MICs and SMICs
of the photodynamic treated (T1) planktonic cultures and
biofilms with those untreated, respectively.
RESULTS
Photodynamic Effects on the Growth of
Planktonic Cultures and Biofilms
The aPDT with methylene blue and LED exhibited CFU
reductions of up to 3.8 log10 and 6.4 log10 against planktonic
Exophiala spp. and Fusarium spp., respecitvely, and 4.2 log10 and
5.6 log10 against biofilms formed by Exophiala spp. and Fusarium
spp., respecitvely, demonstrating efficacy in reducing the growth
of both planktonic cultures and biofilms in all concentrations of
methylene blue (Table 1 and Figures 1A–D).
Photodynamic Effects on Antifungal
Susceptibilities of Planktonic Cultures and
Biofilms
MIC ranges of four drugs against planktonic cells with or without
aPDT were summarized in Table 2. Planktonic E. dermatitidis
without aPDT showed MIC values of 1 µg/ml for ITC and
AMB, and 0.25–0.5 µg/ml for VRC and POS (Table 2). MICs
of planktonic E. dermatitidis decreased to 0.125 µg/ml for ITC
and 0.06 µg/ml for VRC, POS and AMB, respectively, after
aPDT treatment, as shown in Figure 2A. Planktonic culture of
Fusarium spp. without PDT showed high MIC values of ≥16, 4-
8, 4-8, and 2-4 µg/ml for ITC, VRC, POS and AMB, respectively
(Table 2). However, after aPDT treatment, the MIC ranges
decreased to 0.125–0.25, 0.125, 0.06–0.125, and 0.06–0.125µg/ml
for ITC, VRC, POS, and AMB, respectively, as shown in
Figure 2B.
SMIC ranges of four drugs against biofilms with or without
PDT were summarized in Tables 3, 4. Fusarium and Exophiala
biofilms showed high SMIC50 and SMIC80 of ≥16 µg/ml for
all azoles tested. Both biofilms showed variable susceptibilities
to AMB, with SMIC ranging between 1 and 16 µg/ml. Biofilms
that were subjected to aPDT exhibited a distinct reduction
in SMIC50 and SMIC80 compared to untreated groups for
both species, except SMIC80 of ITC against Fusarium biofilms
(Figures 2C–F).
DISCUSSION
Photodynamic inactivation combines the application of a
pharmacologically inert chromophore, termed a photosensitizer
(PS), and subsequent irradiation with visible light corresponding
to the chromophore’s specific absorption wavelength in the
presence of molecular oxygen (Dai et al., 2012). After
photon absorption the PS reaches an energized triplet state,
which can undergo two mechanisms to regain its ground
state. In type I mechanism, the PS directly transfers energy
to a substrate or to molecular oxygen, producing reactive
intermediates such as superoxide anion, hydrogen peroxide,
hydroxyl radials, nitric oxide, and peroxide nitrite, while
in type II mechanism, energy is transferred directly to
molecular oxygen generating highly reactive singlet oxygen
(Wainwright, 1998; Schweitzer and Schmidt, 2003; Hamblin
and Hasan, 2004). The proportion of both mechanisms is
unique for each PS with the singlet oxygen quantum yield 81
describing the proportion of type II mechanism (Maisch et al.,
2007).
A variety of PSs have been used in antifungal photodynamic
inactivation, including toluidine blue, methylene blue, Rose
Bengal, porphyrins, phthalocyanines, 5-aminolevulinic acid, and
curcumin (Calzavara-Pinton et al., 2012; Baltazar et al., 2015). A
newly developed photosensitizer SAPYR, which exhibits a singlet
oxygen quantum yield of 0.99 and absorption wavelength of 360–
420 nm, has been demonstrated stronger effect against bacterial
biofilms than methylene blue that exhibits a singlet oxygen
quantum yield of 0.52 (Cieplik et al., 2015). Phthalocyanines
TABLE 1 | Effect of photodynamic therapy on Exophiala spp. and Fusarium spp.
Strain Planktonic Biofilm
T1 T2 T3 C1 C2 C3 T1 T2 T3 C1 C2 C3
E. dermatitidis (1) 2 × 105 1.6 × 104 1 × 103 2 × 106 1.8 × 106 1.7 × 106 1.5 × 107 2 × 106 4.2 × 104 2.1 × 108 2.4 × 108 2.8 × 108
E. dermatitidis (2) 5 × 104 1 × 104 1 × 103 2.5 × 106 2.2 × 106 2.7 × 106 2.5 × 107 1 × 106 6 × 104 4.5 × 108 3.8 × 108 5.2 × 108
E. dermatitidis (3) 3 × 104 1.5 × 104 8 × 102 3 × 106 2.8 × 106 2.7 × 106 3.2 × 107 4.1 × 106 5 × 104 7.1 × 108 7.9 × 108 6 × 108
E. dermatitidis (4) 2.5 × 104 1 × 103 4 × 102 2.4 × 106 2 × 106 2.2 × 106 5.8 × 106 2 × 105 1.9 × 104 1 × 108 1.5 × 108 1.2 × 108
E. dermatitidis (5) 2.1 × 104 1.3 × 103 5 × 102 5 × 105 4.3 × 105 4.5 × 105 3.4 × 107 1.3 × 106 4 × 104 5.1 × 108 5.5 × 108 4.5 × 108
F. solani (1) 3.2 × 105 1.2 × 103 0 2.7 × 106 2.5 × 106 2.5 × 106 9 × 106 3.5 × 105 1.2 × 103 1.1 × 108 2.1 × 108 1.2 × 108
F. solani (2) 2.8 × 105 2 × 104 0 2.2 × 106 2.4 × 106 2 × 106 3.9 × 107 2 × 106 2 × 103 6.2 × 108 6.6 × 108 7.2 × 108
F. solani (3) 2.7 × 105 8 × 103 0 1.8 × 106 1.6 × 106 2 × 106 2.5 × 107 7 × 105 1 × 103 4 × 108 4.9 × 108 4 × 108
F. oxysporum (1) 1.6 × 105 1.5 × 103 0 2 × 106 1.6 × 106 2.1 × 106 4 × 107 6 × 105 2.5 × 103 5 × 108 5.5 × 108 5.8 × 108
F. oxysporum (2) 1.4 × 105 2 × 103 0 1.8 × 106 2.2 × 106 1.7 × 106 4.5 × 106 8.2 × 105 1 × 103 1.9 × 108 1.1 × 108 1.2 × 108
C1, growth in Sabouraud glucose agar without irradiation or methylene blue; C2, isolates exposed to 16 µg/ml of methylene blue without irradiation; C3 isolates exposed to irradiation
without methylene blue; T1 photodynamic treatment with 8 µg/ml of methylene blue; T2 photodynamic treatment with 16 µg/ml of methylene blue; T3, photodynamic treatment with
32 µg/ml of methylene blue.
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FIGURE 1 | Photodynamic inactivation effects on planktonic and biofilm forms of Exophiala spp. and Exophiala spp. (A) CFU counting of Planktonic
Exophiala spp. (B) CFU counting of Planktonic Fusarium spp. (C) CFU counting of Exophiala Biofilms. (D) CFU counting of Fusarium Biofilms. C1, growth in
Sabouraud glucose agar without irradiation or methylene blue; C2, isolates exposed to 16 µg/ml of methylene blue without irradiation; C3 isolates exposed to
irradiation without methylene blue; T1 photodynamic treatment with 8 µg/ml of methylene blue; T2 photodynamic treatment with 16 µg/ml of methylene blue; T3,
photodynamic treatment with 32 µg/ml of methylene blue. Data are mean values and standard error from three replicate experiments.
TABLE 2 | Effect of photodynamic therapy on MICs of planktonic culture.
Strain MICs (µg/ml)
Planktonic cultures Planktonic cultures with T1 treatment
ITC VRC POS AMB ITC VRC POS AMB
E. dermatitidis (1) 1 0.5 0.5 1 0.06 0.06 0.06 0.06
E. dermatitidis (2) 1 0.25 0.5 1 0.06 0.06 0.06 0.06
E. dermatitidis (3) 1 0.25 0.5 1 0.125 0.06 0.06 0.06
E. dermatitidis (4) 1 0.25 0.5 1 0.06 0.06 0.06 0.06
E. dermatitidis (5) 1 0.5 0.25 1 0.06 0.06 0.06 0.06
F. solani (1) ≥16 8 4 4 0.125 0.125 0.125 0.06
F. solani (2) ≥16 4 4 2 0.25 0.125 0.125 0.125
F. solani (3) ≥16 8 4 4 0.125 0.125 0.125 0.125
F. oxysporum (1) ≥16 8 4 2 0.25 0.125 0.06 0.06
F. oxysporum (2) ≥16 8 8 4 0.125 0.125 0.125 0.125
are also characterized by high singlet oxygen quantum yields
and high extinction coefficient in the far-red (680–720 nm)
spectral region (Bertoloni et al., 1992; Calzavara-Pinton et al.,
2012). A number of synthetic phthalocyanines, including chloro-
aluminum phthalocyanine and silicon phthalocyanine 4, were
demonstrated effective in Candida albicans and Trichophyton
rubrum in vitro (Lam et al., 2011, 2014; Carmello et al., 2016).
However, when choosing a PS for antifungal photodynamic
inactivation, the light penetration is an important concern.
Given that fungal infections involve not only the superficial
skin, but also the subcutaneous tissue, nails, hair, nasal cavity,
oral cavity, esophagus or reproductive tract, some degree of
light penetration is required (Donnelly et al., 2008). Moreover,
dematiaceous fungi possess pigments (melanin), which could
interfere with light absorption. Therefore, for melanized fungi
such as Exophiala spp., the PS selected should absorb light
in a different wavelength from that of the pigment present in
the fungi. It is important to note that methylene blue have
a absorption wavelength over 600 nm, which minimizes the
competition with the melanin maximum absorption wavelength
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FIGURE 2 | Photodynamic effects on antifungal susceptibilities of planktonic and biofilm forms of Exophiala spp. and Exophiala spp. (A) MICs of
Planktonic Exophiala spp. (B) MICs of Planktonic Fusarium spp. (C) SMIC50 of Exophiala biofilm. (D) SMIC50 of Fusarium biofilm. (E) SMIC80 of Exophiala biofilm.
(F) SMIC80 of Fusarium biofilm. ITC, itraconazole; VRC, voriconazole; POS, posaconazole; AMB, amphotericin B. Data are mean values and standard error from three
replicate experiments.
TABLE 3 | Effect of photodynamic therapy on SMIC50 of biofilms.
Strain SMIC50 (µg/ml)
Biofilm Biofilm with T1
treatment
ITC VRC POS AMB ITC VRC POS AMB
E. dermatitidis (1) ≥16 ≥16 ≥16 2 4 4 4 0.5
E. dermatitidis (2) ≥16 ≥16 ≥16 1 4 4 2 0.5
E. dermatitidis (3) ≥16 ≥16 ≥16 2 8 4 4 0.5
E. dermatitidis (4) ≥16 ≥16 ≥16 2 4 2 4 1
E. dermatitidis (5) ≥16 ≥16 ≥16 2 4 4 4 1
F. solani (1) ≥16 ≥16 ≥16 4 4 4 8 2
F. solani (2) ≥16 ≥16 ≥16 8 8 4 4 2
F. solani (3) ≥16 ≥16 ≥16 4 8 4 4 1
F. oxysporum (1) ≥16 ≥16 ≥16 8 8 4 8 2
F. oxysporum (2) ≥16 ≥16 ≥16 8 4 2 4 2
and allows maximal tissue transmission (Lyon et al., 2011a;
Pires et al., 2014). Furthermore, the combination of methylene
blue, which is already clinically approved for human use, and
LED is a very inexpensive and convenient system, and is
TABLE 4 | Effect of photodynamic therapy on SMIC80 of biofilms.
Strain SMIC80 (µg/ml)
Biofilm Biofilm with T1
treatment
ITC VRC POS AMB ITC VRC POS AMB
E. dermatitidis (1) ≥16 ≥16 ≥16 8 2 0.5 0.5 2
E. dermatitidis (2) ≥16 ≥16 ≥16 4 1 0.5 0.5 1
E. dermatitidis (3) ≥16 ≥16 ≥16 4 2 1 1 1
E. dermatitidis (4) ≥16 ≥16 ≥16 4 1 0.5 0.5 1
E. dermatitidis (5) ≥16 ≥16 ≥16 4 1 0.5 0.5 1
F. solani (1) ≥16 ≥16 ≥16 ≥16 16 8 8 4
F. solani (2) ≥16 ≥16 ≥16 ≥16 8 4 4 2
F. solani (3) ≥16 ≥16 ≥16 ≥16 16 8 4 4
F. oxysporum (1) ≥16 ≥16 ≥16 ≥16 16 8 8 2
F. oxysporum (2) ≥16 ≥16 ≥16 ≥16 16 8 8 4
increasingly being used in experimental and clinical applications
of aPDT(Calzavara-Pinton et al., 2012; Dai et al., 2012). We
therefore chose to apply aPDT using methylene blue and LED
irradiation for studying the aPDT effects against planktonic and
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biofilm forms of Fusaruim spp. and Exophiala spp. in an in vitro
assay.
The results in the present study revealed that all isolates tested
were sensitive to photodynamic inactivation, both planktonic
cells and biofilms. Planktonic and biofilm form of Exophiala
spp. exhibited CFU reductions of up to 3.8 log10 and 4.2
log10, respectively, which is declared as biologically relevant
antimicrobial activity (Boyce et al., 2002). Planktonic and
biofilm form of Fusarium spp. exhibited CFU reduction of
up to 6.4 log10 and 5.6 log10,respectively, which is defined
as disinfect effect (Boyce et al., 2002) and has not been
reported in the literature thus far. Previous study has shown in
C. albicans that ATP-binding cassette, a multidrug eﬄux system
was directly implicated in methylene blue eﬄux from the cell
cytoplasm, which might impact the antimicrobial photodynamic
inactivation efficacy (Prates et al., 2011). However, in this study,
Fusarium strains with high MIC values to ITC, VRC and POS
were also sensitive to aPDT mediated by methylene blue. Despite
Exophiala spp. showed relatively better antifungal susceptibility
profile, the inactivation rates of planktonic and biofilm form
of Fusaruim spp. in all treatment groups were comparable or
even superior to Exophiala spp., suggesting that aPDT is active
regardless of antifungal resistance, as described previously (Mima
et al., 2010). This might relate to the principles of the action
of nonspecific oxidizing agents of PDT, which oxidize biological
molecules of the fungi cells in multiple targets (Lyon et al.,
2011a).
Compared to planktonic cells, biofilms were less sensitive to
aPDT since the irradiation time of biofilms was twice longer
than that of planktonic cultures. Previously, biofilms have been
found to be more resistant to aPDT than planktonic cells in
several studies (Donnelly et al., 2007; Chabrier-Roselló et al.,
2008; Dovigo et al., 2011; Costa et al., 2012). Therefore, longer
preirradiation time or higher PS concentrations are needed to
obtain better aPDT response (Donnelly et al., 2007; Chabrier-
Roselló et al., 2008; Dovigo et al., 2011; Costa et al., 2012). In this
study, we were able to achieve satisfactory photodynamic effects
by double the irradiation time of the biofilms. This difference
probably occurred due to the structural characteristics of
biofilms, including restriction of penetration by the extracellular
matrix, the decreased growth rate and heterogeneity of the
biofilm cells, and distinct gene expression levels (Costa et al.,
2012).
We also tested the change of antifungal susceptibilities
of tested strains before and after aPDT treatment, in both
planktonic and biofilm forms. Pre-treatment with aPDT followed
by standard antifungal treatments resulted in dramatic reduction
of MICs and SMICs for both species. Both planktonic
suspensions and biofilms were much more susceptible to
antifungal drug treatments after aPDT, which may due to
the increased membrane permeability caused by photodynamic
inactivation, as demonstrated in previous study (Giroldo et al.,
2009). The results suggest aPDT combined with standard
antifungal treatment may help to enhance the antifungal
susceptibility to overcome problems with drug resistance issues,
and has the potential to reduce drug dosages and drug toxicity.
In general, our results expand the knowledge regarding the
photodynamic inactivation of pathogenic fungi. The in vitro
photodynamic therapy with methylene blue and LED was
efficient in inhibiting the growth of Fusaruim spp. and Exophiala
spp., both planktonic cultures and biofilms. In addition, the
combination of aPDT and antifungal drugs represents an
attractive alternative to the current antifungal strategies for
infections of Fusaruim spp. and Exophiala spp., which has
the potential to reduce treatment times, drug dosages, drug
toxicity and improve patient compliance. However, despite the
encouraging results, further investigations including in vivo
experimental and clinical studies are warranted to determine
clear protocols for the reliable and safe application in clinical
practice.
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